Last reviewed · How we verify

NCT05457777

The Effect of Motivational Interviews on the Digital Game Addiction Levels of Nursing Students

Completed NA Last updated 6 September 2023
What this trial tests

NA trial testing Motivational interview in digital game addiction in Motivational Interview in 72 participants. Completed in 22 October 2022.

Timeline
22 May 2022
Primary endpoint
22 September 2022
22 October 2022

Quick facts

Lead sponsorFidan Balkaya
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment72
Start date22 May 2022
Primary completion22 September 2022
Estimated completion22 October 2022
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Fidan Balkaya

Who can join

18 and older, any sex, with Motivational Interview or Addiction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to reveal the effect of motivational interviewing based on change stages on digital game addiction. This study will be conducted with a total of 72 individuals assigned by a randomization site from all nursing students who study at Sivas Cumhuriyet University, Faculty of Health Sciences, voluntarily participated in the study, and were found to be digital game addicts. These individuals will be equally distributed to the intervention and control groups. Personal Information Form, Stages of Change Questionnaire and Digital Game Addiction Scale will be distributed to individuals to answer. The obtained data will be analyzed statistically.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Fidan Balkaya trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05457777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing